Biomarker analyses from a phase III, randomized, open-label, first-line study of gefitinib (G) versus carboplatin/paclitaxel (C/P) in clinically selected patients (pts) with advanced non-small cell lung cancer (NSCLC) in Asia (IPASS)
Other conference paper

Full Text

Times Cited
Web of Science16WOS source URL (as at 11/08/2020) Click here for the latest count

Other information
All Author(s) ListFukuoka M, Wu Y, Thongprasert S, Yang C, Chu D, Saijo N, Watkins C, Duffield E, Armour A, Mok T
Name of Conference45th Annual Meeting of the American-Society-of-Clinical-Oncology
Start Date of Conference29/05/2009
End Date of Conference02/06/2009
Place of ConferenceOrlando
Country/Region of ConferenceUnited States of America
Journal nameJournal of Clinical Oncology
Detailed descriptionorganized by ASCO,
Volume Number27
Issue Number15
PublisherAmerican Society of Clinical Oncology
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesOncology; ONCOLOGY

Last updated on 2020-12-08 at 02:35